These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15241487)

  • 1. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.
    Domina AM; Vrana JA; Gregory MA; Hann SR; Craig RW
    Oncogene; 2004 Jul; 23(31):5301-15. PubMed ID: 15241487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.
    Domina AM; Smith JH; Craig RW
    J Biol Chem; 2000 Jul; 275(28):21688-94. PubMed ID: 10777489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.
    Townsend KJ; Trusty JL; Traupman MA; Eastman A; Craig RW
    Oncogene; 1998 Sep; 17(10):1223-34. PubMed ID: 9771965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
    Vrana JA; Cleaveland ES; Eastman A; Craig RW
    Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.
    McDaid HM; Horwitz SB
    Mol Pharmacol; 2001 Aug; 60(2):290-301. PubMed ID: 11455016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation.
    Townsend KJ; Zhou P; Qian L; Bieszczad CK; Lowrey CH; Yen A; Craig RW
    J Biol Chem; 1999 Jan; 274(3):1801-13. PubMed ID: 9880563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.
    De Biasio A; Vrana JA; Zhou P; Qian L; Bieszczad CK; Braley KE; Domina AM; Weintraub SJ; Neveu JM; Lane WS; Craig RW
    J Biol Chem; 2007 Aug; 282(33):23919-36. PubMed ID: 17561513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine inhibits paclitaxel‑induced apoptosis in colorectal cancer cells through the upregulation of Mcl‑1 levels.
    Mhaidat NM; Alzoubi KH; Al-Azzam SI; Alsaad AA
    Mol Med Rep; 2014 Jan; 9(1):243-8. PubMed ID: 24173825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-O-tetradecanoyl phorbol 13-acetate, protein kinase C (PKC) activator, protects human leukemia HL-60 cells from taxol-induced apoptosis: possible role for extracellular signal-regulated kinase.
    Pae HO; Yoo JC; Choi BM; Lee EJ; Song YS; Chung HT
    Immunopharmacol Immunotoxicol; 2000 Feb; 22(1):61-73. PubMed ID: 10737257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.
    Deng X; Kornblau SM; Ruvolo PP; May WS
    J Natl Cancer Inst Monogr; 2001; (28):30-7. PubMed ID: 11158204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.
    Nifoussi SK; Ratcliffe NR; Ornstein DL; Kasof G; Strack S; Craig RW
    J Biol Chem; 2014 Aug; 289(32):21950-9. PubMed ID: 24939844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
    Lee YC; Chen YJ; Huang CH; Chang LS
    Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of major ERK-related phosphorylation sites in Gab1.
    Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
    Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of BCL2 family member MCL1 as an early response to DNA damage.
    Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW
    Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells.
    Pushkarev VM; Starenki DV; Saenko VA; Namba H; Kurebayashi J; Tronko MD; Yamashita S
    Endocrinology; 2004 Jul; 145(7):3143-52. PubMed ID: 15044368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
    Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M
    Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
    Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
    Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.